Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells

Chao Qu; Xiao-Zhen Fu; Chao Han; Qian Chen; Yan Liu; Xiao-bo Wang; Rong-Gang Xi; Jing Liu; Wei Zou

doi:doi:10.11648/j.ab.20140206.14

| Peer-Reviewed

Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells

Chao Qu, Xiao-Zhen Fu, Chao Han, Qian Chen, Yan Liu, Xiao-bo Wang, Rong-Gang Xi, Jing Liu, Wei Zou

Published in Advances in Biochemistry (Volume 2, Issue 6)

Received: 4 December 2014 Accepted: 22 December 2014 Published: 31 December 2014

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: Parkinson’s disease (PD) is the second most common neurodegenerative disease and afflicts almost 1.8% of over 65-year-old group in the world. Epidemiological projections showed that the incidence of PD was increasing continuously each year, with a wider age range as well. A large number of studies indicated that voltage-gated potassium channel (Kv) played significant roles in cellular signaling in both excitable and non-excitable cells. What’s more, Kv was also ubiquitously expressed in neurons and participated in signaling pathway in neurons. Kv1.5 (encoded by KCNA5) is an important voltage-gated K+ channel, which is not only necessary for critical processes such as cell proliferation and apoptosis but ubiquitously expressed in neurons. Recent studies reported that PD clinical drugs could inhibit the expression of Kv1.5. To determine the mechanisms by which Kv1.5 protects against MPP+ mediated neurotoxicity in PC12 cells. Materials and Methods: Knockdown of Kv1.5 model was established with pSINsi-hU6- Kv1.5 treated by the RNAi method in PC12. MTT, and Western Blot were used to detect the influence of Kv1.5 on PC12 proliferation, and the effect of Kv1.5 on PC12 apoptosis after MPP+ treatment in vitro. Results: 1) Knockdown and overexpression of Kv1.5 participated in PC12 proliferation. Transiently over-expressed Kv1.5 could boost the survival rate of PC12, while transiently knockdown of Kv1.5 inhibited PC12 proliferation. 2) The effect of Kv1.5 on PC12 proliferation was through PI3K/Akt signaling pathway. Over-expressed Kv1.5 could induce the activation of Akt, and Bcl-2 expression in PC12; Knockdown of Kv1.5 in PC12 inhibited the activation of Akt, Bcl-2 expression, and promoted MAPK phosphorylation. 3) Over-expressed Kv1.5 could significantly prevent PC12 from apoptosis induced by MPP+ via activating Akt pathway and increasing Bcl-2 expression; Knockdown of Kv1.5 was more sensitive than its control counterpart when treated with MPP+ for 24 h. Conclusion: Kv1.5 could hinder MPP+ neurotoxicity to PC12 by PI3K/Akt signaling pathway.

Published in	Advances in Biochemistry (Volume 2, Issue 6)
DOI	10.11648/j.ab.20140206.14
Page(s)	103-108
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

PC12, Kv1.5, MPP+, PD, PI3K/Akt

References

[1]	Finnegan KT, Irwin I, Delanney LE and Langston JW(1995) Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B. J Pharmacol Exp Ther 273: 716-20.
[2]	De Rijk MC LL, Berger K(2000) Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurology 54: S21-S23.
[3]	Yang SF WQ, Sun AS(2001) Protective effect and mechanism on Ginkgo biloba leaf extracts for Parkinson disease in-duced by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine. Acta Pharmacol Sin 22: 1893-93.
[4]	Yim SB, Park SE, Lee CS(2007) Protective effect of glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells. J Pharmacol Exp Ther 321: 816-22.
[5]	Ye Q, Ye L, Xu X, Huang B, Zhang X, Zhu Y and Chen X(2012) Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1alpha signaling pathway. BMC Complement Altern Med 12: 82.
[6]	Phuket TR and Covarrubias M(2009) Kv4 Channels Underlie the Subthreshold-Operating A-type K-current in Nociceptive Dorsal Root Ganglion Neurons. Front Mol Neurosci 2: 3.
[7]	Wang Z(2004) Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch 448: 274-86.
[8]	Melanie Spitzner JO, Kerstin Scheidt(2007) Voltage-gated K+ channels support proliferation of colonic carcinoma cells. The FASEB Journal 21: 35-40.
[9]	Jansson B, Jankovic J(1985) Low cancer rates among patients with Parkinson's disease. Ann Neurol 17: 505-9.
[10]	Sutton AC, Yu W, Calos ME, Mueller LE, Berk M, Shim J, Molho ES, Brotchie JM, Carlen PL and Shin DS(2012): Elevated potassium provides an ionic mechanism for deep brain stimulation in the hemiparkinsonian rat. Eur J Neurosci 37: 231-41.
[11]	Dehui Hu JL, James Keblesh(2010) Involvement of the 4-aminopyridine sensitive transient A-type K+ current in macrophage-induced neuronal injury. Eur J Neurosci 31: 214-22.
[12]	Svoboda LK, Reddie KG, Zhang L, Vesely ED, Williams ES, Schumacher SM, O'Connell RP, Shaw R, Day SM, Anumonwo JM, Carroll KS, Martens JR(2012) Redox-sensitive sulfenic acid modification regulates surface expression of the cardiovascular voltage-gated potassium channel Kv1.5. Circ Res 111: 842-53.
[13]	Bielanska J, Hernandez-Losa J, Moline T, Somoza R, Cajal SR, Condom E, Ferreres JC, Felipe A(2012) Increased voltage-dependent K(+) channel Kv1.3 and Kv1.5 expression correlates with leiomyosarcoma aggressiveness. Oncol Lett 4: 227-30.
[14]	Zhai FG, Zhang XH, Wang HL(2009) Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats. Clin Exp Pharmacol Physiol 36: 850-6.
[15]	Mullen KM, Rozycka M, Rus H, Hu L, Cudrici C, Zafranskaia E, Pennington MW, Johns DC, Judge SI, Calabresi PA(2006) Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system. Ann Neurol 60: 118-27.
[16]	Vianna-Jorge R, Oliveira CF, Garcia ML, Kaczorowski GJ, Suarez-Kurtz G(2003) Shaker-type Kv1 channel blockers increase the peristaltic activity of guinea-pigileum by stimulating acetylcholine and tachykinins release by the enteric nervous system. Br J Pharmacol 138: 57-62.
[17]	Karina Alviña KK(2010) The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. J Neurosci 30: 7258-68.
[18]	Wang YP, Tang JF, Lin JF, Cai XH, Wang XT, Zheng GQ(2008) Potassium channels: possible new therapeutic targets in Parkinson's disease. Med Hypotheses 71: 546-50.
[19]	Wang G ZJ, Shen CY, Wang ZQ, Chen SD(2008) Overexpression of Kir2.3 in PC12 cells resists rotenone-induced neurotoxicity associated with PKC signaling pathway. Biochem Biophys Res Commun 374: 204-9.
[20]	Mot AI WA, Sinclair L, Brown DR, Collins SJ, Brazier MW(2011) Metal attenuating therapies in neurodegenerative disease. Expert Rev Neurother 11: 1717-45.
[21]	Bisaglia M TI, Mammi S, Bubacco L(2009) Interaction between alpha-synuclein and metal ions, still looking for a role in the pathogenesis of Parkinson's disease. Neuromolecular Med 11: 239-51.
[22]	Gui YX, Xiao Q, Wang Y, Wang G, Chen SD(2011) Verification of expressions of Kir2 as potential peripheral biomarkers in lymphocytes from patients with Parkinson's disease. Neurosci Lett 505: 104-8.
[23]	Hong ZG, Andrew J, Smith MD, Stephen L, Archer MD(2005) Pergolide Is an Inhibitor of Voltage-Gated Potassium Channels, Including Kv1.5, and Causes Pulmonary Vasoconstriction. Circulation 112: 1494-9.
[24]	Dai F MZ, Xia J, Zhu S, Wu Z(2012) Fluoxetine protects against big endothelin-1 induced anti-apoptosis by rescuing Kv1.5 channels in human pulmonary arterial smooth muscle cells. Yonsei Med J 53: 842-8.
[25]	Bielanska J H-LJ, Moline T, Somoza R, Ramón y Cajal S, Condom E, Ferreres JC, Felipe A(2012) Differential expression of Kv1.3 and Kv1.5 voltage-dependent K+ channels in human skeletal muscle sarcomas. Cancer Invest 30: 203-8.
[26]	Liou AK ZZ, Pei W, Lim TM, Yin XM, Chen J(2005) BimEL up-regulation potentiates AIF translocation and cell death in response to MPTP. Faseb J 19: 1350-2.
[27]	Quigney DJ GA, Samali A(2003) Heat shock protects PC12 cells against MPP+ toxicity. Brain Res 993:133-9.
[28]	Zhang L DW, Sun H, Zhou Q, Huang J, Li X, Xie Y, Chen J(2012) Salidroside protects PC12 cells from MPP+-induced apoptosis via activation of the PI3K/Akt pathway. Food Chem Toxicol 50: 2591-7.
[29]	Liu Y PW, Yang S, Wu X, Wu J, Ma J, Yuan Z, Meng S(2012) Interleukin-22 protects rat PC12 pheochromocytoma cells from serum deprivation-induced cell death. Mol Cell Biochem 371: 137-146.

Cite This Article

Plain Text BibTeX RIS

APA Style

Chao Qu, Xiao-Zhen Fu, Chao Han, Qian Chen, Yan Liu, et al. (2014). Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells. Advances in Biochemistry, 2(6), 103-108. https://doi.org/10.11648/j.ab.20140206.14

Copy | Download

ACS Style

Chao Qu; Xiao-Zhen Fu; Chao Han; Qian Chen; Yan Liu, et al. Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells. Adv. Biochem. 2014, 2(6), 103-108. doi: 10.11648/j.ab.20140206.14

Copy | Download

AMA Style

Chao Qu, Xiao-Zhen Fu, Chao Han, Qian Chen, Yan Liu, et al. Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells. Adv Biochem. 2014;2(6):103-108. doi: 10.11648/j.ab.20140206.14

Copy | Download

@article{10.11648/j.ab.20140206.14,
  author = {Chao Qu and Xiao-Zhen Fu and Chao Han and Qian Chen and Yan Liu and Xiao-bo Wang and Rong-Gang Xi and Jing Liu and Wei Zou},
  title = {Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells},
  journal = {Advances in Biochemistry},
  volume = {2},
  number = {6},
  pages = {103-108},
  doi = {10.11648/j.ab.20140206.14},
  url = {https://doi.org/10.11648/j.ab.20140206.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ab.20140206.14},
  abstract = {Background: Parkinson’s disease (PD) is the second most common neurodegenerative disease and afflicts almost 1.8% of over 65-year-old group in the world. Epidemiological projections showed that the incidence of PD was increasing continuously each year, with a wider age range as well. A large number of studies indicated that voltage-gated potassium channel (Kv) played significant roles in cellular signaling in both excitable and non-excitable cells. What’s more, Kv was also ubiquitously expressed in neurons and participated in signaling pathway in neurons. Kv1.5 (encoded by KCNA5) is an important voltage-gated K+ channel, which is not only necessary for critical processes such as cell proliferation and apoptosis but ubiquitously expressed in neurons. Recent studies reported that PD clinical drugs could inhibit the expression of Kv1.5. To determine the mechanisms by which Kv1.5 protects against MPP+ mediated neurotoxicity in PC12 cells. Materials and Methods: Knockdown of Kv1.5 model was established with pSINsi-hU6- Kv1.5 treated by the RNAi method in PC12. MTT, and Western Blot were used to detect the influence of Kv1.5 on PC12 proliferation, and the effect of Kv1.5 on PC12 apoptosis after MPP+ treatment in vitro. Results: 1) Knockdown and overexpression of Kv1.5 participated in PC12 proliferation. Transiently over-expressed Kv1.5 could boost the survival rate of PC12, while transiently knockdown of Kv1.5 inhibited PC12 proliferation. 2) The effect of Kv1.5 on PC12 proliferation was through PI3K/Akt signaling pathway. Over-expressed Kv1.5 could induce the activation of Akt, and Bcl-2 expression in PC12; Knockdown of Kv1.5 in PC12 inhibited the activation of Akt, Bcl-2 expression, and promoted MAPK phosphorylation. 3) Over-expressed Kv1.5 could significantly prevent PC12 from apoptosis induced by MPP+ via activating Akt pathway and increasing Bcl-2 expression; Knockdown of Kv1.5 was more sensitive than its control counterpart when treated with MPP+ for 24 h. Conclusion: Kv1.5 could hinder MPP+ neurotoxicity to PC12 by PI3K/Akt signaling pathway.},
 year = {2014}
}

Copy | Download

TY  - JOUR
T1  - Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells
AU  - Chao Qu
AU  - Xiao-Zhen Fu
AU  - Chao Han
AU  - Qian Chen
AU  - Yan Liu
AU  - Xiao-bo Wang
AU  - Rong-Gang Xi
AU  - Jing Liu
AU  - Wei Zou
Y1  - 2014/12/31
PY  - 2014
N1  - https://doi.org/10.11648/j.ab.20140206.14
DO  - 10.11648/j.ab.20140206.14
T2  - Advances in Biochemistry
JF  - Advances in Biochemistry
JO  - Advances in Biochemistry
SP  - 103
EP  - 108
PB  - Science Publishing Group
SN  - 2329-0862
UR  - https://doi.org/10.11648/j.ab.20140206.14
AB  - Background: Parkinson’s disease (PD) is the second most common neurodegenerative disease and afflicts almost 1.8% of over 65-year-old group in the world. Epidemiological projections showed that the incidence of PD was increasing continuously each year, with a wider age range as well. A large number of studies indicated that voltage-gated potassium channel (Kv) played significant roles in cellular signaling in both excitable and non-excitable cells. What’s more, Kv was also ubiquitously expressed in neurons and participated in signaling pathway in neurons. Kv1.5 (encoded by KCNA5) is an important voltage-gated K+ channel, which is not only necessary for critical processes such as cell proliferation and apoptosis but ubiquitously expressed in neurons. Recent studies reported that PD clinical drugs could inhibit the expression of Kv1.5. To determine the mechanisms by which Kv1.5 protects against MPP+ mediated neurotoxicity in PC12 cells. Materials and Methods: Knockdown of Kv1.5 model was established with pSINsi-hU6- Kv1.5 treated by the RNAi method in PC12. MTT, and Western Blot were used to detect the influence of Kv1.5 on PC12 proliferation, and the effect of Kv1.5 on PC12 apoptosis after MPP+ treatment in vitro. Results: 1) Knockdown and overexpression of Kv1.5 participated in PC12 proliferation. Transiently over-expressed Kv1.5 could boost the survival rate of PC12, while transiently knockdown of Kv1.5 inhibited PC12 proliferation. 2) The effect of Kv1.5 on PC12 proliferation was through PI3K/Akt signaling pathway. Over-expressed Kv1.5 could induce the activation of Akt, and Bcl-2 expression in PC12; Knockdown of Kv1.5 in PC12 inhibited the activation of Akt, Bcl-2 expression, and promoted MAPK phosphorylation. 3) Over-expressed Kv1.5 could significantly prevent PC12 from apoptosis induced by MPP+ via activating Akt pathway and increasing Bcl-2 expression; Knockdown of Kv1.5 was more sensitive than its control counterpart when treated with MPP+ for 24 h. Conclusion: Kv1.5 could hinder MPP+ neurotoxicity to PC12 by PI3K/Akt signaling pathway.
VL  - 2
IS  - 6
ER  -

Copy | Download

Author Information

Chao Qu

College of Life Science, Liaoning Normal University, Dalian 116081, China
Xiao-Zhen Fu

College of Life Science, Liaoning Normal University, Dalian 116081, China
Chao Han

College of Life Science, Liaoning Normal University, Dalian 116081, China
Qian Chen

College of Life Science, Liaoning Normal University, Dalian 116081, China
Yan Liu

College of Life Science, Liaoning Normal University, Dalian 116081, China
Xiao-bo Wang

The 210th Hospital of PLA, Dalian 116015, Liaoning, Province, China
Rong-Gang Xi

The 210th Hospital of PLA, Dalian 116015, Liaoning, Province, China
Jing Liu

Centre for Regenerative Medicine, First Affiliated Hospital of Dalian Medical University, Dalian 116011, Liaoning Province, China
Wei Zou

College of Life Science, Liaoning Normal University, Dalian 116081, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Chao Qu, Xiao-Zhen Fu, Chao Han, Qian Chen, Yan Liu, et al. (2014). Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells. Advances in Biochemistry, 2(6), 103-108. https://doi.org/10.11648/j.ab.20140206.14

Copy | Download

ACS Style

Chao Qu; Xiao-Zhen Fu; Chao Han; Qian Chen; Yan Liu, et al. Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells. Adv. Biochem. 2014, 2(6), 103-108. doi: 10.11648/j.ab.20140206.14

Copy | Download

AMA Style

Chao Qu, Xiao-Zhen Fu, Chao Han, Qian Chen, Yan Liu, et al. Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells. Adv Biochem. 2014;2(6):103-108. doi: 10.11648/j.ab.20140206.14

Copy | Download

@article{10.11648/j.ab.20140206.14,
  author = {Chao Qu and Xiao-Zhen Fu and Chao Han and Qian Chen and Yan Liu and Xiao-bo Wang and Rong-Gang Xi and Jing Liu and Wei Zou},
  title = {Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells},
  journal = {Advances in Biochemistry},
  volume = {2},
  number = {6},
  pages = {103-108},
  doi = {10.11648/j.ab.20140206.14},
  url = {https://doi.org/10.11648/j.ab.20140206.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ab.20140206.14},
  abstract = {Background: Parkinson’s disease (PD) is the second most common neurodegenerative disease and afflicts almost 1.8% of over 65-year-old group in the world. Epidemiological projections showed that the incidence of PD was increasing continuously each year, with a wider age range as well. A large number of studies indicated that voltage-gated potassium channel (Kv) played significant roles in cellular signaling in both excitable and non-excitable cells. What’s more, Kv was also ubiquitously expressed in neurons and participated in signaling pathway in neurons. Kv1.5 (encoded by KCNA5) is an important voltage-gated K+ channel, which is not only necessary for critical processes such as cell proliferation and apoptosis but ubiquitously expressed in neurons. Recent studies reported that PD clinical drugs could inhibit the expression of Kv1.5. To determine the mechanisms by which Kv1.5 protects against MPP+ mediated neurotoxicity in PC12 cells. Materials and Methods: Knockdown of Kv1.5 model was established with pSINsi-hU6- Kv1.5 treated by the RNAi method in PC12. MTT, and Western Blot were used to detect the influence of Kv1.5 on PC12 proliferation, and the effect of Kv1.5 on PC12 apoptosis after MPP+ treatment in vitro. Results: 1) Knockdown and overexpression of Kv1.5 participated in PC12 proliferation. Transiently over-expressed Kv1.5 could boost the survival rate of PC12, while transiently knockdown of Kv1.5 inhibited PC12 proliferation. 2) The effect of Kv1.5 on PC12 proliferation was through PI3K/Akt signaling pathway. Over-expressed Kv1.5 could induce the activation of Akt, and Bcl-2 expression in PC12; Knockdown of Kv1.5 in PC12 inhibited the activation of Akt, Bcl-2 expression, and promoted MAPK phosphorylation. 3) Over-expressed Kv1.5 could significantly prevent PC12 from apoptosis induced by MPP+ via activating Akt pathway and increasing Bcl-2 expression; Knockdown of Kv1.5 was more sensitive than its control counterpart when treated with MPP+ for 24 h. Conclusion: Kv1.5 could hinder MPP+ neurotoxicity to PC12 by PI3K/Akt signaling pathway.},
 year = {2014}
}

Copy | Download

TY  - JOUR
T1  - Voltage-Gated Potassium Channel KV1.5 Protects against MPP+ Mediated Neurotoxicity in PC12 Cells
AU  - Chao Qu
AU  - Xiao-Zhen Fu
AU  - Chao Han
AU  - Qian Chen
AU  - Yan Liu
AU  - Xiao-bo Wang
AU  - Rong-Gang Xi
AU  - Jing Liu
AU  - Wei Zou
Y1  - 2014/12/31
PY  - 2014
N1  - https://doi.org/10.11648/j.ab.20140206.14
DO  - 10.11648/j.ab.20140206.14
T2  - Advances in Biochemistry
JF  - Advances in Biochemistry
JO  - Advances in Biochemistry
SP  - 103
EP  - 108
PB  - Science Publishing Group
SN  - 2329-0862
UR  - https://doi.org/10.11648/j.ab.20140206.14
AB  - Background: Parkinson’s disease (PD) is the second most common neurodegenerative disease and afflicts almost 1.8% of over 65-year-old group in the world. Epidemiological projections showed that the incidence of PD was increasing continuously each year, with a wider age range as well. A large number of studies indicated that voltage-gated potassium channel (Kv) played significant roles in cellular signaling in both excitable and non-excitable cells. What’s more, Kv was also ubiquitously expressed in neurons and participated in signaling pathway in neurons. Kv1.5 (encoded by KCNA5) is an important voltage-gated K+ channel, which is not only necessary for critical processes such as cell proliferation and apoptosis but ubiquitously expressed in neurons. Recent studies reported that PD clinical drugs could inhibit the expression of Kv1.5. To determine the mechanisms by which Kv1.5 protects against MPP+ mediated neurotoxicity in PC12 cells. Materials and Methods: Knockdown of Kv1.5 model was established with pSINsi-hU6- Kv1.5 treated by the RNAi method in PC12. MTT, and Western Blot were used to detect the influence of Kv1.5 on PC12 proliferation, and the effect of Kv1.5 on PC12 apoptosis after MPP+ treatment in vitro. Results: 1) Knockdown and overexpression of Kv1.5 participated in PC12 proliferation. Transiently over-expressed Kv1.5 could boost the survival rate of PC12, while transiently knockdown of Kv1.5 inhibited PC12 proliferation. 2) The effect of Kv1.5 on PC12 proliferation was through PI3K/Akt signaling pathway. Over-expressed Kv1.5 could induce the activation of Akt, and Bcl-2 expression in PC12; Knockdown of Kv1.5 in PC12 inhibited the activation of Akt, Bcl-2 expression, and promoted MAPK phosphorylation. 3) Over-expressed Kv1.5 could significantly prevent PC12 from apoptosis induced by MPP+ via activating Akt pathway and increasing Bcl-2 expression; Knockdown of Kv1.5 was more sensitive than its control counterpart when treated with MPP+ for 24 h. Conclusion: Kv1.5 could hinder MPP+ neurotoxicity to PC12 by PI3K/Akt signaling pathway.
VL  - 2
IS  - 6
ER  -

Copy | Download